Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway

Cellular Physiology and Biochemistry (2015) 37 (2): 454–464.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Traditional Chinese medication qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the phosphoinositide 3-kinase/protein kinase B/forkhead box O3 axis
  • Ningxia Wu
  • Jianing Chi
  • Hua Cai
  • Jiaman Hu
  • Yingying Lai
  • Cailong Lin
  • Liang Kang
  • Jingping Sun
  • Jianyu Huang
  • Min Li
  • Lin Xu
Journal of Ethnopharmacology (2025) 337: 118821.
Qiliqiangxin capsule alleviates cardiac hypertrophy and cardiac dysfunction by regulating miR-382-5p/ATF3 axis
  • Bao Yin
  • XiaoTong Jiang
  • XinFeng Chang
  • ChunHua Song
Clinics (2024) 79: 100496.
Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
  • Tongxing Wang
  • Bin Hou
  • Haoran Qin
  • Junqing Liang
  • Min Shi
  • Yanfei Song
  • Kun Ma
  • Meng Chen
  • Huixin Li
  • Guoyuan Ding
  • Bing Yao
  • Zhixin Wang
  • Cong Wei
  • Zhenhua Jia
Heliyon (2023) 9 (11): e21950.
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
  • Milton Packer
European Journal of Heart Failure (2023) 25 (12): 2130.
Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
  • Alice Yeuk Lan Leung
  • Hoiyong Chen
  • Zhenhua Jia
  • Xinli Li
  • Jiangang Shen
Chinese Medicine (2021) 16 (1)
Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
  • Wenming Yao
  • Iokfai Cheang
  • Shengen Liao
  • Yanli Zhou
  • Fang Zhou
  • Dongjie Xu
  • Zhenhua Jia
  • Liping Chang
  • Haifeng Zhang
  • Xinli Li
BMC Complementary Medicine and Therapies (2020) 20 (1)
Zishen Huoxue Recipe Protecting Mitochondrial Function of Hypoxic/Reoxygenated Myocardial Cells through mTORC1 Signaling Pathway
  • Ruxiu Liu
  • Xing Chang
  • Jie Li
  • Yao Shunyu
  • Elia Ranzato
Evidence-Based Complementary and Alternative Medicine (2020) 2020 (1)
New Challenges and Strategies for Cardiac Disease: Autophagy, mTOR, and AMP-activated Protein Kinase
  • Kenneth Maiese
Current Neurovascular Research (2020) 17 (2): 111.
An inhibitor role of Nrf2 in the regulation of myocardial senescence and dysfunction after myocardial infarction
  • Xinxia Luo
  • Junyang Zhou
  • Zhixiao Wang
  • Yun He
  • Li Yu
  • Shinan Ma
  • Shan Wang
  • Xiaoli Wang
  • Yahong Yuan
  • Dongsheng Li
  • Taixing Cui
  • Yan Ding
Life Sciences (2020) 259: 118199.
Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy
  • Tao Zhang
  • Jianrong Guo
  • Jian Gu
  • Ke Chen
  • Huili Li
  • Jiliang Wang
Oxidative Medicine and Cellular Longevity (2019) 2019: 1.
Retracted: Effects of mTOR/NF‐κB signaling pathway and high thoracic epidural anesthesia on myocardial ischemia‐reperfusion injury via autophagy in rats
  • Wei‐Qiang Huang
  • Jian‐Lin Wen
  • Ri‐Qi Lin
  • Peng Wei
  • Feng Huang
Journal of Cellular Physiology (2018) 233 (9): 6669.
Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion
  • Jing-Yan Han
  • Quan Li
  • Zhi-Zhong Ma
  • Jing-Yu Fan
Pharmacology & Therapeutics (2017) 177: 146.
Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG‐1/ErbB‐PI3K/Akt/mTOR pathway
  • Jingfeng Wang
  • Jingmin Zhou
  • Yanyan Wang
  • Chunjie Yang
  • Mingqiang Fu
  • Jingjing Zhang
  • Xueting Han
  • Zhiming Li
  • Kai Hu
  • Junbo Ge
Journal of Cellular and Molecular Medicine (2017) 21 (9): 1905.
Inhibition of cardiotrophin-1 overexpression is involved in the anti-fibrotic effect of Astrogaloside IV
  • Guizhi Jia
  • Bin Leng
  • Hongxin Wang
  • Hongliang Dai
Molecular Medicine Reports (2017) 16 (6): 8365.
Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1
  • Gui-hao Chen
  • Chuan-sheng Xu
  • Jie Zhang
  • Qing Li
  • He-he Cui
  • Xiang-dong Li
  • Li-ping Chang
  • Rui-jie Tang
  • Jun-yan Xu
  • Xia-qiu Tian
  • Pei-sen Huang
  • Jun Xu
  • Chen Jin
  • Yue-jin Yang
Frontiers in Pharmacology (2017) 8
Autophagy in cardiac metabolic control: Novel mechanisms for cardiovascular disorders
  • Yufei Yang
  • Cong Zhao
  • Pingzhen Yang
  • Xianbao Wang
  • Lizi Wang
  • Aihua Chen
Cell Biology International (2016) 40 (9): 944.
  • Online ISSN 1421-9778
  • Print ISSN 1015-8987
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal